MedPAC targets prescription drug spending, seeks bundled payment options

Why This Topic Matters

The article is relevant to practices that bill Medicare for Part B drugs and to organizations tracking payment reform, because it discusses proposed changes that could affect reimbursement patterns, care coordination, and specialty-specific revenue mix.

Article Sections

1. Physician payments

   Introduces the article’s focus on Medicare drug payment policy and the broader reimbursement context for physician offices.

2. Minimize the price discrepancy between current high-dollar and inexpensive drugs

   Covers MedPAC’s discussion of alternative payment structures for physician-administered drugs and the policy goals behind those options.

3. Create a value-based prescription payment methodology to spur on coordinated care

   Describes MedPAC’s interest in broader bundled or episode-based payment approaches and the implications for coordinated care.